• Add this page to "Favorite pages"
  • Print the text(Open link in a new browser window)
Here begins the text.

PMDA-ATC Pharmaceuticals Review Seminar 2020 postponed to December


The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to announce the holding of the “PMDA-ATC Pharmaceuticals Review Seminar 2020" for officials from overseas regulatory authorities who are engaged in the review of pharmaceuticals.
The Seminar will be offered by the Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA-ATC) at PMDA Office in Tokyo, and in Toyama prefecture for site visit, from May 18-22, 2020.

The Seminar will cover topics relating to product review for new drugs, generic drugs and biosimilars, and efficient review pathways for early access as well, through the lectures and case studies to promote comprehensive understanding of the regulatory systems.

The aims of the Seminar are to provide chances for the participants to refer back to their work and to find any additional opportunity for enhancement of the participants’ regulatory systems.

The seminar is not open to the industry or non-regulatory authorities.
Participation from many regulatory authorities is welcomed.

Key Seminar Objective

  1. To learn basics of regulations and regulatory organization
  2. To learn the key regulatory flow of the product development to post-approval

The Seminar will focus on the following key regulatory activities.

  • Consultations (Scientific Advice)
  • Product review
  • Efficient review pathways for early access
  1. To make use of the learnings from case studies and discussions and reflect it back to the regulatory system in the participant's organization.

Who should apply

  • Employees of regulatory authorities, or other agencies/institutes closely related thereto.
  • Pharmaceutical reviewer with at least 3 years of experience in the review of pharmaceuticals.
  • Basic knowledge of the regulations pertaining to the pharmaceuticals review in his/her organization is required.
Other Points to Note
  • The training will be provided in English (with consecutive translation in some sessions).
  • All participants are expected to actively participate in all of the sessions.
  • There will be a session in which the participant from each country/region gives a brief presentation on the situations of his/her organization with regard to the pharmaceuticals review.


May 18-22, 2020 December 14-17
In order to prevent COVID-19 prevalence, the seminar is postponed to December.

Program (subject to change)

Draft program will be posted in September.


Number of participants: approx. 30
Close of registration: March 11, 2020

Registration will be reopened in September.
Note: All submitted applications by March 11 will be effective for the rearranged event.

  • Registration request should be made by filling in all the necessary items including signature by the Head of the Organization on the application form (attached).Please send the form in both the Word file (without signature) and the PDF file (with signature) by e-mail to the e-mail address shown in “Contact Us” below.
  • Early registration is recommended. After the closing date, any change or addition of participant(s) may not be accepted. Please be sure to allow enough time to obtain the visa for entry to Japan, as all the travel arrangements must be fixed before visa application.
  • If the number of applications exceeds the capacity, selection of the participants will take place at the discretion of PMDA based on the information provided in the application form.
  • Confirmation of the registration and additional information will be sent to the approved participants after the close of registration.


There is no registration fee for this seminar.
Information on travel and hotel reservation assistance will be announced to the approved participants.


Pharmaceuticals and Medical Devices Agency (PMDA):

Shin-kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan



Please use public transportation. Nearest Tokyo Metro Subway Stations:

  • 5 minutes' walk from Exit 11 of Toranomon Station on the Ginza Line
  • 8 minutes' walk from Exit 3 of Kokkai-gijido-mae Station, on the Marunouchi Line, Chiyoda Line
  • 8 minutes' walk from Exit A13 of Kasumigaseki Station, on the Marunouchi Line, Chiyoda Line, Hibiya Line
  • 10 minutes' walk from Exit 8 of Tameike-sanno Station, on the Ginza Line, Namboku Line

Contact Us

For more information, please contact:

Secretariat, PMDA Asia Training Center
E-mail: PMDA-ATC●pmda.go.jp

Office of International Cooperation
Pharmaceuticals and Medical Devices Agency
Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

(Note: For the purpose of security, @ in the e-mail addresses are replaced with ●. Please replace ● with @ when you send an e-mail.)

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.